학술논문
Real‐life effectiveness of iGlarLixi (insulin glargine 100 U/mL and lixisenatide) in people with type 2 diabetes according to prior insulin use.
Document Type
Article
Author
Source
Subject
*TYPE 2 diabetes
*INSULIN
*INSULIN therapy
*INSULIN aspart
*
*
*
Language
ISSN
1462-8902
Abstract
This article presents a study that examines the effectiveness and safety of iGlarLixi, a treatment for type 2 diabetes, in both individuals who have not previously used insulin and those who have. The study found that iGlarLixi improved glycemic control, with a greater reduction in HbA1c levels seen in insulin-naïve participants. The treatment was well-tolerated, with few instances of hypoglycemia and gastrointestinal adverse events. The study concludes that iGlarLixi is a safe and effective option for managing type 2 diabetes. [Extracted from the article]